PLSM News

Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026 Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026 PR Newswire OMER, Israel, Aug. 24, 2026 OMER, Israel...

Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring PR Newswire RAMAT...

Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program PR Newswire RAMAT GAN, Israel, Aug. 17...

From a transformational merger and corporate restructuring at Twin Vee PowerCats, to encouraging Phase 2 clinical data from Q32 Bio, major oncology financing by Agenus, government-backed AI development at Pulsenmore, shareholder returns from LogProstyle, and new third-party testing validating Xeriant's advanced construction materials, this week's developments demonstrate the diverse catalysts capable of reshaping small-cap growth stories. $VEEE, $XERI, $PLSM, $LGPS, $QTTB, $AGEN

For fans of Austin Powers, the phrase "One million dollars!" became one of cinema's most memorable jokes, but Pulsenmore’s (NASDAQ:PLSM) newly announced $1 million government-backed artificial intelligence initiative could represent something far more meaningful than a punchline. The company has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program, led by the Israel Innovation Authority and the Ministry of Health, to develop and clinically validate AI applications for its connected home ultrasound platform.

Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-market session. The company's market cap stands at $25.1 million. Q32 Bio (NASDAQ:QTTB) stock rose 65.92% to $18.6. Theread more...

Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project PR Newswire RAMAT GAN, Israel, July 13...

Pulsenmore (NASDAQ: PLSM) stock dips premarket after announcing a $7.5M private placement to fund its U.S. commercial expansion.read more...

Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor PR Newswire RAMAT GAN, Israel, June 25, 2026 RAMAT GAN...